Wagner Paul A.'s Form 4 filing
Forte Biosciences, Inc. (FBRX) · filed Nov 22, 2023
- Accession no.
- 0001209191-23-056522
- Filed
- Nov 22, 2023, 5:51 PM ET
- Trade date
- Nov 20-22, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $3.22K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wagner Paul A.CIK 0001612842 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | Common Stock | PPurchaseAcquired | +5,300 | $0.44 | +$2,332 | 1,709,671 | Direct | |
| Nov 20, 2023 | Common Stock | PPurchaseAcquired | +1,566 | $0.43 | +$673.38 | 1,711,237 | Direct | |
| Nov 20, 2023 | Common Stock | PPurchaseAcquired | +100 | $0.4251 | +$42.51 | 1,711,337 | Direct | |
| Nov 22, 2023 | Common Stock | PPurchaseAcquired | +400 | $0.43 | +$172 | 1,711,737 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.